Table 3. Retention at three, six, and 12 months among PLHIV newly initiated on ART, before (April–June 2015) and during “Treat All” * (April–June 2017) in 50 ePMS ART sites ^ in Harare, Zimbabwe.
| ART outcomes | Before “Treat All” | During “Treat All” | P – value # | ||
|---|---|---|---|---|---|
| N | % | N | (%) | ||
| Total | 2289 | (100.0) | 1682 | (100.0) | |
| Three months | |||||
| Retained in care | 1905 | (83.2) | 1359 | (80.8) | 0.053 |
| Attrition | |||||
| Died | 2 | (<0.1) | 0 | (0.0) | |
| LTFU | 381 | (16.7) | 320 | (19.0) | |
| Stopped ART | 1 | (<0.1) | 3 | (<0.1) | |
| Six months | |||||
| Retained in care | 1787 | (78.1) | 1260 | (74.9) | 0.02 |
| Attrition | |||||
| Died | 2 | (<0.1) | 0 | (0.0) | |
| LTFU | 499 | (21.8) | 419 | (24.9) | |
| Stopped ART | 1 | (<0.1) | 3 | (<0.1) | |
| 12 months | |||||
| Retained in care | 1667 | (72.8) | 1203 | (71.5) | 0.38 |
| Attrition | |||||
| Died | 2 | (<0.1) | 1 | (<0.1) | |
| LTFU | 619 | (27.1) | 475 | (28.3) | |
| Stopped ART | 1 | (<0.1) | 3 | (<0.1) | |
PLHIV: people living with human immunodeficiency virus; ART: antiretroviral therapy; ePMS: electronic patient management system; LFTU: loss to follow up.
*” Treat All” means all individuals with confirmed HIV diagnosis are eligible for ART irrespective of WHO clinical stage or CD4 count.
^As on October 2018, the 50 ePMS sites constituted 52% of all people on ART in Harare province.
#z test of proportions (proportion retained in care).